logo
Plus   Neg
Share
Email

Bausch Health Plans To Spin Off Eye Health Business

Bausch Health Companies Inc. (BHC,BHC.TO) announced Thursday it intends to spin off its eye health business into an independent publicly traded entity from the remainder of Bausch Health.

In pre-market activity, Bausch Health shares gained 20 percent to trade at $23.32.

The spinoff will establish two separate companies, such as a fully integrated, pure play eye-health company built on the iconic Bausch + Lomb brand, as well as a diversified pharmaceutical company.

The new Bausch + Lomb - NewCo will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses. It would have had 2019 revenue of approximately $3.7 billion.

Further, BHC will comprise a diversified portfolio of durable brands across the Salix, International Rx, Solta, neurology and medical dermatology businesses. It would have had 2019 revenue of approximately $4.9 billion.

The timing of the anticipated spinoff will be tied to certain conditions and approvals, and the Company's completion of several important actions, including the reorganization of the reporting segments, which it expects to begin reporting in the first quarter of 2021.

The transaction is expected to enable BHC to focus on expanding Gastroenterology, Aesthetics/Dermatology, Neurology and International pharmaceuticals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT